Budecort
Developed for asthma indicated to alleviate airway inflammation.
Strengths: 100mcg
Where to Check Availability
Medicine details
- Alternative names
Pulmicort; Budelin
- Therapeutic class
Inhaled Corticosteroid
- Pharmacological class
Corticosteroid
- Contraindications
hypersensitivity to budesonide; acute bronchospasm
- Precautions and warnings
rinse mouth after use; monitor growth in children; regular review of dose
- Minor side effects
oral candidiasis; hoarseness; throat irritation
- Moderate side effects
cough; respiratory tract infection
- Dosage forms
Inhalation powder
- Administration route
Inhalation use
- Patient summary
Developed for asthma indicated to alleviate airway inflammation.
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
24–48 hours
- Duration
12 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
ketoconazole
- Age restrictions
Use as directed by age group guidelines.
- Pregnancy and breastfeeding
Pregnancy: Use lowest effective dose. Breastfeeding: Can be used.
Serious side effects
adrenal suppression — requires immediate medical attention; anaphylaxis — requires immediate medical attention
Mechanism of action
Budesonide possesses potent glucocorticoid activity, exerting profound anti-inflammatory effects in the bronchi by reducing mucosal oedema and bronchial hyper-responsiveness.
Budecort
Developed for asthma indicated to alleviate airway inflammation.
Editorial Notes
- Active ingredient(s): Budesonide
- Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease
Available option
- 2 inhalers - 100 mcg1074-100-mcg-14252